CompoAtlas

Complete Essentials with 4th Generation PRODUCT B IsaGenesis for Women

Originaltext auf Französisch.

In Kanada zugelassenes natürliches Gesundheitsprodukt

Falls dieses Produkt in Frankreich verkauft würde

Eine Tagesmenge wird nur bei ausdrücklicher oraler Dosierung für Erwachsene berechnet, die pro Tag und in einer zur Produktform passenden festen Einheit angegeben ist. Mehrdeutige Einheiten, Flüssigkeiten, Pulver und pädiatrische Dosen werden nicht hochgerechnet. Eine nicht berechnete Menge wird nicht mit Dosisgrenzwerten verglichen. Diese Analyse stellt weder eine Verkaufszulassung in Frankreich noch eine Sicherheits- oder Wirksamkeitsbewertung dar.

Zusammensetzung

Arzneilicher Inhaltsstoff und QuelleJe Dosiseinheit laut QuelleTäglich höchstens, Erwachsene
Bioflavonoïdes d'agrumes

Quelle : Citrus sinensis - fruit

10 milligrammeNicht berechnet
Bioflavonoïdes d'agrumes

Quelle : Citrus limon - Fruit

10 milligrammeNicht berechnet
Bioflavonoïdes d'agrumes

Quelle : Citrus paradisi - Fruit

10 milligrammeNicht berechnet
Shilajit

Quelle : Purified mineral pitch

3 milligrammeNicht berechnet
Calcium

Quelle : Carbonate de calcium

225 milligrammeNicht berechnet
Calcium

Quelle : Hydroxyapatite de calcium

225 milligrammeNicht berechnet
Calcium

Quelle : Gluconate de calcium

225 milligrammeNicht berechnet
Calcium

Quelle : Citrate de calcium

225 milligrammeNicht berechnet
Linum usitatissimum

Quelle : Linum usitatissimum - Graine

30 milligrammeNicht berechnet
Camellia sinensis

Quelle : Camellia sinensis - Extrait de Feuille

Stärke : 30 % Catechins

6 milligrammeNicht berechnet
Vitamine B12

Quelle : Cyanocobalamine

7,5 microgrammesNicht berechnet
Lycium chinense

Quelle : Écorce de racine

Extrakt : Matériel brut sec

Extraktionsverhältnis : 4:1

Trockenpflanzenäquivalent : 2 milligramme

0,5 milligrammeNicht berechnet
Boron

Quelle : Citrate de bore

250 microgrammesNicht berechnet
Vitis Vinifera

Quelle : Vitis vinifera - Graine

Stärke : 80 % Oligomeric proanthocyanidins

10 milligrammeNicht berechnet
Withania somnifera

Quelle : Withania somnifera - racine

Extrakt : Matériel brut sec

Extraktionsverhältnis : 4:1

Trockenpflanzenäquivalent : 55 milligramme

13,75 milligrammeNicht berechnet
bêta-carotène

Quelle : bêta-carotène

1 milligrammeNicht berechnet
Vitamine D

Quelle : Cholécalciférol

1,25 milligrammeNicht berechnet
Vitamine E

Quelle : d-alpha tocophérol

10 mg ATNicht berechnet
Vitamine E

Quelle : d-alpha tocophérol

15 UINicht berechnet
Camellia sinensis

Quelle : Camellia sinensis - feuille

Stärke : 30 % Epigallocatechin 3 galate

2 milligrammeNicht berechnet
Camellia sinensis

Quelle : Camellia sinensis - feuille

Stärke : 0,6 milligramme Epigallocatechin 3 galate

Nicht angegebenNicht berechnet
Camellia sinensis

Quelle : Camellia sinensis - feuille

Stärke : 35 % Epigallocatechin 3-gallate

32 milligrammeNicht berechnet
Riboflavine

Quelle : Riboflavine

2,125 milligrammeNicht berechnet
Biotine

Quelle : Biotine

125 microgrammesNicht berechnet
Acide pantothénique

Quelle : D-pantothénate de calcium

11,25 milligrammeNicht berechnet
Magnésium

Quelle : Produit de chélation de magnésium et de protéine végétale hydrolysée (PVH)

50 milligrammeNicht berechnet
Magnésium

Quelle : Citrate de magnésium

50 milligrammeNicht berechnet
Magnésium

Quelle : Oxyde de magnésium

50 milligrammeNicht berechnet
Sélénium

Quelle : Produit de chélation de sélénium et de protéine végétale hydrolysée (PVH)

25 microgrammesNicht berechnet
Vanadium

Quelle : Produit de chélation de vanadium et de PVH

1,25 microgrammesNicht berechnet
(2S)-7-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one

Quelle : Citrus limon - Fruit

150 microgrammesNicht berechnet
(2S)-7-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one

Quelle : Citrus sinensis - fruit

150 microgrammesNicht berechnet
Oenothera biennis

Quelle : Oenothera biennis - huile de graine

Stärke : 9 % GLA (Gamma Linolenic Acid)

20 milligrammeNicht berechnet
Oenothera biennis

Quelle : Oenothera biennis - huile de graine

Stärke : 1,8 milligramme GLA (Gamma Linolenic Acid)

Nicht angegebenNicht berechnet
(3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol

Quelle : Tagetes erecta - Fleur

0,5 milligrammeNicht berechnet
Niacinamide

Quelle : Niacinamide

5 milligrammeNicht berechnet
Curcuma longa

Quelle : Curcuma longa - rhizome

0,5 milligrammeNicht berechnet
Acide linoléique conjugué

Quelle : Carthamus tinctorius - oil

325 milligrammeNicht berechnet
Bêta-carotene-3,3'-diol totalement trans-

Quelle : Tagetes erecta - Fleur

0,16 milligrammeNicht berechnet
3,3',4',5,7-Pentahydroxyflavone

Quelle : Quercétine dihydraté

4 milligrammeNicht berechnet
Vitamin K2

Quelle : Ménaquinones

20 microgrammesNicht berechnet
Thiamine

Quelle : Chlorhydrate de thiamine

1,875 milligrammeNicht berechnet
Vitamine B6

Quelle : Chlorhydrate de pyridoxine

2,5 milligrammeNicht berechnet
Folate

Quelle : Acide folique

150 microgrammesNicht berechnet
Iode

Quelle : Varech

50 microgrammesNicht berechnet
Iode

Quelle : Iodure de potassium

50 microgrammesNicht berechnet
Zinc

Quelle : Oxyde de zinc

3,75 milligrammeNicht berechnet
Zinc

Quelle : Produit de chélation de zinc et de protéine végétale hydrolysée (PVH)

3,75 milligrammeNicht berechnet
Zinc

Quelle : Citrate de zinc

3,75 milligrammeNicht berechnet
Cuivre

Quelle : Copper HVP chelate

500 microgrammesNicht berechnet
Manganèse

Quelle : Produit de chélation de manganèse et de PVH

0,5 milligrammeNicht berechnet
Chrome

Quelle : Produit de chélation de chrome (III) et de protéine végétale hydrolysée (PVH)

50 microgrammesNicht berechnet
Molybdène

Quelle : Produit de chélation de molybdène et de protéine végétale hydrolysée (PVH)

18,75 microgrammesNicht berechnet
Potassium

Quelle : Citrate de potassium

12,5 milligrammeNicht berechnet
2-hydroxy-N,N,N-triméthyléthanaminium

Quelle : Bitartrate de choline

1,25 milligrammeNicht berechnet
Linum usitatissimum

Quelle : Linum usitatissimum - Graine

Stärke : 4 % Lignans

6,75 milligrammeNicht berechnet
Vitis Vinifera

Quelle : Vitis vinifera - Graine

Stärke : 85 % Oligomeric Proanthocyanidins

7 milligrammeNicht berechnet
Acide DL-alpha lipoÏque

Quelle : Acide DL-alpha-lipoÏque

2 milligrammeNicht berechnet
Bioflavonoïdes d'agrumes

Quelle : Citrus sinensis - Écorce de fruit

1 milligrammeNicht berechnet
Bioflavonoïdes d'agrumes

Quelle : Citrus aurantifolia - Pelure (fruit)

1 milligrammeNicht berechnet
Camellia sinensis

Quelle : Camellia sinensis - feuille

Stärke : 11,2 milligramme Epigallocatechin 3-gallate

Nicht angegebenNicht berechnet
Coptis chinensis

Quelle : Coptis chinensis - Rhizome

Extraktionsverhältnis : 5:1

Trockenpflanzenäquivalent : 15 milligramme

3 milligrammeNicht berechnet
1,2-dithiolane-3-pentanoic acid, (R)

Quelle : Acide R-alpha lipoïque

6 milligrammeNicht berechnet
Epimedium sagittatum

Quelle : Sommité

Extrakt : Matériel brut sec

Extraktionsverhältnis : 5:1

Trockenpflanzenäquivalent : 150 milligramme

30 milligrammeNicht berechnet
L-Glutathione

Quelle : Glutathione

5 milligrammeNicht berechnet
N-acétyl-l-cystéine

Quelle : N-Acétyl-L-cystéine

9 milligrammeNicht berechnet
Lepidium meyenii

Quelle : Lepidium meyenii - racine

Extrakt : Matériel brut sec

Extraktionsverhältnis : 4:1

Trockenpflanzenäquivalent : 12 milligramme

3 milligrammeNicht berechnet
Mucuna pruriens

Quelle : Mucuna pruriens - graine

Extrakt : Matériel brut sec

Extraktionsverhältnis : 4:1

Trockenpflanzenäquivalent : 12 milligramme

3 milligrammeNicht berechnet
Panax ginseng

Quelle : Panax ginseng - racine

Extrakt : Matériel brut sec

Extraktionsverhältnis : 25:1

Trockenpflanzenäquivalent : 125 milligramme

5 milligrammeNicht berechnet
Rubus idaeus

Quelle : rubus idaeus - fruit

Extrakt : Matériel brut sec

Extraktionsverhältnis : 10:1

Trockenpflanzenäquivalent : 50 milligramme

5 milligrammeNicht berechnet
Silybum marianum

Quelle : Silybum marianum - Graine

Stärke : 55 % Silymarin

160 milligrammeNicht berechnet
Silybum marianum

Quelle : Silybum marianum - Graine

Stärke : 88 milligramme Silymarin

Nicht angegebenNicht berechnet
Terminalia chebula

Quelle : Terminalia chebula fruit

4 milligrammeNicht berechnet
Reynoutria japonica

Quelle : Reynoutria Japonica - racine

Stärke : 50 % Resveratrol

31 milligrammeNicht berechnet
Reynoutria japonica

Quelle : Reynoutria Japonica - racine

Stärke : 15,5 milligramme Resveratrol

Nicht angegebenNicht berechnet
Vaccinium angustifolium

Quelle : Vaccinium angustifolium - Fruit

Extrakt : Matériel brut sec

Extraktionsverhältnis : 4:1

Trockenpflanzenäquivalent : 36 milligramme

9 milligrammeNicht berechnet
Vaccinium myrtillus

Quelle : Vaccinium myrtillus - Fruit

Extrakt : Matériel brut sec

Extraktionsverhältnis : 4:1

Trockenpflanzenäquivalent : 28 milligramme

7 milligrammeNicht berechnet
Vitamine B12

Quelle : Vitamine B12

6 microgrammesNicht berechnet
Acide L-ascorbique

Quelle : Acide ascorbique

6,5 milligrammeNicht berechnet
Boswellia serrata

Quelle : Gum oleoresin

Extrakt : Matériel brut sec

Extraktionsverhältnis : 5:1

Trockenpflanzenäquivalent : 45 milligramme

9 milligrammeNicht berechnet
Vitamine D

Quelle : Cholécalciférol

10 microgrammesNicht berechnet
Vitamine D

Quelle : Cholécalciférol

400 UINicht berechnet
Vitamine E

Quelle : d-alpha tocophérol

3,35 mg ATNicht berechnet
Vitamine E

Quelle : d-alpha tocophérol

5 UINicht berechnet
Bêta-carotène tout trans

Quelle : bêta-carotène

750 microgrammesNicht berechnet
Vitamine C

Quelle : Ascorbate de magnésium

30 milligrammeNicht berechnet
Vitamine C

Quelle : Ascorbate de calcium

30 milligrammeNicht berechnet
Vitamine C

Quelle : Ascorbate de sodium

30 milligrammeNicht berechnet
Bioflavonoïdes d'agrumes

Quelle : Citrus limon - Pelure (fruit)

1 milligrammeNicht berechnet
Bioflavonoïdes d'agrumes

Quelle : Citrus reticulata - Pelure (fruit)

1 milligrammeNicht berechnet
Bioflavonoïdes d'agrumes

Quelle : Citrus paradisi - Pelure (fruit)

1 milligrammeNicht berechnet
3,3',4',5,7-Pentahydroxyflavone-3-rutinoside

Quelle : Sophora japonica, flower

1 milligrammeNicht berechnet
Silybum marianum

Quelle : Silybum marianum - Graine

Stärke : 80 % Silymarin

2 milligrammeNicht berechnet
Punica granatum

Quelle : Punica granatum, Fruit

Extraktionsverhältnis : 4:1

Trockenpflanzenäquivalent : 8 milligramme

2 milligrammeNicht berechnet
Acide L-alpha-acétamido-bêta-mercaptopropionique

Quelle : L-alpha-Acetamido-beta-mercaptopropionic acid

2 milligrammeNicht berechnet
Vitamine C

Quelle : Ascorbate de magnésium

520 milligrammeNicht berechnet
Vitamine C

Quelle : Ascorbate de calcium

520 milligrammeNicht berechnet
Vitamine C

Quelle : Ascorbate de sodium

520 milligrammeNicht berechnet
Vitis Vinifera

Quelle : Vitis vinifera - Graine

Extraktionsverhältnis : 4:1

Trockenpflanzenäquivalent : 20 milligramme

5 milligrammeNicht berechnet
3,3',4',5,7-Pentahydroxyflavone

Quelle : Quercétine dihydraté

20 milligrammeNicht berechnet
Huile de poisson

Quelle : Huile du corps de Sardine

Stärke : 300 milligramme EPA (Eicosapentaenoic Acid)

1.000 milligrammeNicht berechnet
Huile de poisson

Quelle : Huile du corps d'Anchois

Stärke : 300 milligramme EPA (Eicosapentaenoic Acid)

1.000 milligrammeNicht berechnet
Borago officinalis

Quelle : Borage seed oil

Stärke : 22 % GLA (Gamma Linolenic Aicd)

20 milligrammeNicht berechnet
Borago officinalis

Quelle : Borage seed oil

Stärke : 4,4 milligramme GLA (Gamma Linolenic Aicd)

Nicht angegebenNicht berechnet
Huile de poisson

Quelle : Huile du corps de Sardine

Stärke : 240 milligramme DHA (Docosahexaenoic Acid)

Nicht angegebenNicht berechnet
Huile de poisson

Quelle : Huile du corps d'Anchois

Stärke : 240 milligramme DHA (Docosahexaenoic Acid)

Nicht angegebenNicht berechnet
Huile de poisson

Quelle : Huile du corps de Sardine

Stärke : 60 milligramme Other Omega fatty acids

Nicht angegebenNicht berechnet
Huile de poisson

Quelle : Huile du corps d'Anchois

Stärke : 60 milligramme Other Omega fatty acids

Nicht angegebenNicht berechnet
Punica granatum

Quelle : Huile de graines

50 milligrammeNicht berechnet
Linum usitatissimum

Quelle : Huile de graines

20 milligrammeNicht berechnet
2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl

Quelle : Synthétique

50 milligrammeNicht berechnet
Acide DL-alpha lipoÏque

Quelle : Acide DL-alpha-lipoÏque

0,5 milligrammeNicht berechnet
Vitis Vinifera

Quelle : Vitis vinifera - Fruit

0,5 milligrammeNicht berechnet
Trans-resvératrol

Quelle : Reynoutria Japonica - racine

25 milligrammeNicht berechnet
Punica granatum

Quelle : Punica granatum, Fruit

Extrakt : Matériel brut sec

Extraktionsverhältnis : 4:1

Trockenpflanzenäquivalent : 2 milligramme

0,5 milligrammeNicht berechnet
Withania somnifera

Quelle : Withania somnifera - racine

Extrakt : Matériel brut sec

Extraktionsverhältnis : 5:1

Trockenpflanzenäquivalent : 2,5 milligramme

Stärke : 1,5 % Withanaloids

0,5 milligrammeNicht berechnet
Concentré de tocotriénol

Quelle : Elaeis guineensis - Fruit

20 milligrammeNicht berechnet
Mélange de concentré de tocophérol5,3 milligrammeNicht berechnet
Curcuma longa

Quelle : Curcuma longa - rhizome

32 milligrammeNicht berechnet
Acacia nilotica

Quelle : Écorce âgée

Extrakt : Matériel brut sec

Extraktionsverhältnis : 12:1

Trockenpflanzenäquivalent : 24 milligramme

2 milligrammeNicht berechnet
Bacopa monnieri

Quelle : Bacopa monnieri - plante entière

Extrakt : Matériel brut sec

Extraktionsverhältnis : 25:1

Trockenpflanzenäquivalent : 125 milligramme

5 milligrammeNicht berechnet
Camellia sinensis

Quelle : Camellia sinensis - feuille

Extrakt : Matériel brut sec

Extraktionsverhältnis : 5:1

Trockenpflanzenäquivalent : 10 milligramme

2 milligrammeNicht berechnet

Nicht arzneiliche Inhaltsstoffe

Dextrine, Vitamine E, Croscarmellose de sodium, Lycopène, Maltodextrine, Caramel, Saveur de citron, Palmitate d'ascorbyle, Cire de Carnauba, Dioxyde de silicium, Amidon de maïs, Sorbitol, Microcrystalline cellulose, Eau purifiée, Mélange de concentré de tocophérol, Hypromellose, Bicarbonate de sodium, Lécithine, huile d'olive, rouge de betterave, Huile de noix de coco vierge, Huile de tournesol, Stéarate de magnésium, Glycérine, Extrait de Medicago Sativa (Luzerne), Carraghénine, Gélatine, Monoglycerides, Corn Oil, Sucrose, Carbonate de calcium, Jus concentré de grenade, Saveur de lime, Huile de graines de lin, Extrait de romarin, Hydroxypropylcellulose

In Kanada empfohlene Dosen

BevölkerungsgruppeAlterMenge pro EinnahmeHäufigkeit
Adultes de sexe fémininNon précisée1 pack2 Tous les jours

In Kanada zugelassene Verwendungen

Source of vitamin A for the maintenance of good health. Source of vitamin A to help maintain eyesight, skin, membranes and immune function. Source of vitamin A to help in the development and maintenance of night vision. Source of vitamin A to help in the development and maintenance of bones and teeth. Helps the body to metabolize carbohydrates, fats and proteins. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps to produce and repair connective tissue. Helps in tissue formation. Helps in connective tissue formation. Helps in wound healing. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis. Helps in the absorption and use of calcium and phosphorus. Helps normal growth and development. Helps to form red blood cells. Helps in the function of the thyroid gland. Helps to maintain proper muscle function. Helps to maintain healthy skin. Helps to maintain immune function. Provides support for healthy glucose metabolism. Source of antioxidants for the maintenance of good health. An antioxidant. An antioxidant for the maintenance of good health. A factor in the maintenance of good health. Helps to prevent vitamin C, vitamin E, vitamin B6, vitamin B12, thiamine, riboflavin, niacin, folate, biotin, pantothenic acid, iodine, zinc, selenium, copper, chromium, and molybdenum deficiencies. Source of omega-3 fatty acids, EPA, and DHA for the maintenance of good health. Helps support cognitive health and/or brain function. Helps maintain/support cardiovascular health. Helps to reduce serum triglycerides/ triacylglycerols. Helps to prevent vitamin D deficiency. Provides antioxidants which can help reduce damage to telomeres, provide telomere support, and contribute to telomere maintenance. Provides antioxidants that help in telomere support and maintenance. Provides antioxidants for the maintenance of good health. Provides antioxidants. Milk Thistle is traditionally used in Herbal Medicine as a hepatoprotectant/liver protectant. Milk Thistle is used in Herbal Medicine to help support liver function. Used in Herbal Medicine to help relieve digestive disturbances/dyspepsia. Provitamin A to help maintain eyesight, skin membranes and immune function. Provitamin A to help in the development and maintenance of night vision, bones, and teeth. Used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels. Used in Herbal Medicine to help support cognitive function and/or reduce mental fatigue (in cases of mental stress). Used in Herbal Medicine to help enhance physical capacity/performance (in cases of physical stress). Provides antioxidants which can help reduce damage to telomeres, provide telomere support, and contribute to telomere maintenance.

Originaltext auf Englisch.

Eine in Kanada zugelassene Verwendung ist keine in der Europäischen Union zugelassene gesundheitsbezogene Angabe. Beachten Sie das Register gesundheitsbezogener Angaben.

Warnhinweise in Kanada

Known Adverse Reactions : Hypersensitivity, such as allergy, has been known to occur; in which case, discontinue use. Some people may experience insomnia, anxiety, or headaches, in which case, discontinue use. Some people may experience mild gastrointestinal disturbances such as diarrhoea, abdominal pain, heartburn, nausea and vomiting; in which case, discontinue use. Rare, unpredictable cases of liver injury associated with green tea extract-containing products have been reported (in Canada and internationally).

Originaltext auf Englisch.

Cautions and Warnings : Consult a health care practitioner prior to use if you have been diagnosed with estrogen-dependant cancer, if you are taking blood pressure medication, if you have diabetes or if you are taking other medications (i.e. drugs or natural health products), have a kidney, or have diabetes, cystinuria, and/or have an iron deficiency, or if you are taking blood thinners. Consult a healthcare practitioner prior to use if you have gallstones, stomach ulcers, excess stomach acid, or if you are taking antiplatelet medication or cardiac glycosides such as digitalis/digoxin. If you have a liver disorder, consult a health care practitioner prior to use. Stop use if you develop symptoms of liver trouble such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/or loss of appetite and consult a health care practitioner. Consult a health care practitoner prior to use if you are taking antidepressant medications. For Adult use only: If you are taking prescription medication, consult a healthcare practitioner prior to use as resveratrol may alter the effectiveness of these medications. Consult a health care practitioner for prolonged use, or if symptoms persist or worsen. If you are a tobacco smoker, consult a health care practitioner prior to use. If you experience symptoms of hypoglycaemia including feelings of anxiety, dizziness, tremor, sweating, nausea or headache, discontinue use and consult a health care practitioner. If you have kidney stones, consult a health care practitioner prior to use.

Originaltext auf Englisch.

Contra-Indications : Do not use if you are pregnant or breastfeeding or if you have a bile duct obstruction. Consumption with alcohol, other drugs, or natural health products with sedative properties is not recommended. If you are taking antibiotics, do not use this product.

Originaltext auf Englisch.

Produktdaten

Andere Namen
Complete Essentials IsaGenesis Daily Pack for Women, Complete Essentials with IsaGenesis Daily Pack for Women
Inhaber
Isagenix Canada ULC
NPN oder DIN-HM
80072117
Status
Aktive Lizenz
Lizenzdatum
18. August 2016
Überarbeitungsdatum
16. November 2016
Form
Kit
Verabreichungsweg
Orale
Art des Antrags
Non traditionnelle

Quelle

Amtlicher Health-Canada-Eintrag, Zulassung 80072117

Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise, abgerufen am 27. Oktober 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Originaltext auf Englisch.

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Originaltext auf Französisch.

Die unter demselben Namen in Europa verkaufte Rezeptur kann abweichen. Diese Angaben ersetzen keinen ärztlichen oder pharmazeutischen Rat.

Offizielle Warnhinweise (Health Canada)

Health Canada veröffentlicht Warnhinweise zu diesen Zutaten:

  • Linum usitatissimum
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    FLAXSEED - LINUM USITATISSIMUM

    Art der Anwendung: Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Gilt für Produkte: providing 5 g or more of flaxseed per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).

    Von Health Canada zitierte Quellen (1)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).

    Von Health Canada zitierte Quellen (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.

    Anwendungsbedingung: Laxative; Promotion of bowel movement; Constipation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).

    Von Health Canada zitierte Quellen (2)
    • Pray WS. 2006. Non-Prescription Product Therapeutics, 2nd edition. New York (NY): Lippincott Williams & Wilkins.
    • Repchinsky 2002: Canadian Pharmacists Association. Patient Self-Care. Helping Patients Make Therapeutic Choices. Ottawa (ON): Canadian Pharmacists Association.

    Gegenanzeigen

    Gilt für Produkte: providing 5 g or more of flaxseed per day.

    Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).

    Von Health Canada zitierte Quellen (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).

    Von Health Canada zitierte Quellen (4)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
    • Gardner Z. and McGuffin M. editors. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. American Herbal Products Association. Boca Raton (FL): CRC Press; 2013.

    Bekannte Nebenwirkungen

    Anwendungsbedingung: All products.

    Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).

    Von Health Canada zitierte Quellen (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • León F, Rodríguez M, Cuevas M. 2003. Anaphylaxis to Linum. Allergologia et immunopathologia 31(1):47-49.

    Monografie von Health Canada vom 26. Juli 2024

  • Withania somnifera
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    ASHWAGANDHA - WITHANIA SOMNIFERA

    Art der Anwendung: Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Anwendungsbedingung: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Anwendungsbedingung: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).

    Von Health Canada zitierte Quellen (3)
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).

    Von Health Canada zitierte Quellen (3)
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
    • Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.

    Monografie von Health Canada vom 28. Februar 2025

  • Vitamine D
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    VITAMIN D (>1,000 - 2,500 IU)

    Art der Anwendung: Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Anwendungsbedingung: All products except products containing zinc sourced from picolinate requiring a contraindication.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Anwendungsbedingung: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).

    Von Health Canada zitierte Quellen (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).

    Von Health Canada zitierte Quellen (3)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NNHPD 2021. Natural and Non-Prescription Health Products Directorate. Internal evidence and HC's product monographs.
    • DPSNSO 2021. Direction des produits de santé naturels et sans ordonnance. Preuves internes et monographies de produits internes de SC.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.

    Gilt für Produkte: containing vitamin K2.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).

    Von Health Canada zitierte Quellen (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Gilt für Produkte: providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).

    Von Health Canada zitierte Quellen (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Gegenanzeigen

    Anwendungsbedingung: All products.

    Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).

    Von Health Canada zitierte Quellen (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Gilt für Produkte: containing zinc sourced from picolinate.

    Do not use if you are pregnant or breastfeeding (NNHPD 2026).

    Von Health Canada zitierte Quellen (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Bekannte Nebenwirkungen

    Anwendungsbedingung: All products.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).

    Von Health Canada zitierte Quellen (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Gilt für Produkte: providing more than 350 mg of magnesium per day.

    When using this product you may experience diarrhea (NNHPD 2026).

    Von Health Canada zitierte Quellen (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Monografie von Health Canada vom 26. Juni 2026

  • Oenothera biennis
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen
  • Curcuma longa
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    TURMERIC - CURCUMA LONGA - Oral

    Art der Anwendung: Oral (ESCOP 2003; Blumenthal et al. 2000)

    Vorsichtsmaßnahmen und Warnhinweise

    Anwendungsbedingung: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (ESCOP 2003; Brinker 2001; McGuffin et al. 1997).

    Von Health Canada zitierte Quellen (2)
    • ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.

    1 im Text zitierte Studie hat keine passende Angabe im Literaturverzeichnis der Monografie (siehe Auffälligkeiten auf der Quellenseite).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder (HC 2025; EMA 2018; Brinker 2010; ESCOP 2003; McGuffin et al. 1997).

    Von Health Canada zitierte Quellen (6)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2018. European Medicines Agency. European Union herbal monograph on Curcuma longa L., rhizome. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 25 September 2018. [Accessed 2023 October 14] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-curcuma-longa-l-rhizoma-revision-1_en.pdf
    • ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).

    Von Health Canada zitierte Quellen (2)
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).

    Von Health Canada zitierte Quellen (2)
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Anwendungsbedingung: All uses except for Source of antioxidants and Hepatoprotectant.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Monografie von Health Canada vom 26. September 2025

    Turmeric -CURCUMA LONGA - Topical

    Vorsichtsmaßnahmen und Warnhinweise

    For external use only.

    When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Gegenanzeigen

    Do not use on deep or puncture wounds, animal bites or serious burns.

    Monografie von Health Canada vom 28. Februar 2025

  • Acide linoléique conjugué
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    CONJUGATED LINOLEIC ACID

    Art der Anwendung: Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are obese or have cardiovascular disease (CVD) risk factors (Tholstrup et al. 2008; Gaullier et al. 2007; Steck et al. 2007; Larsen et al. 2006; Taylor et al. 2006; Gaullier et al. 2005; Smedman et al. 2005; Gaullier et al. 2004; Basu et al. 2000a,b).

    Von Health Canada zitierte Quellen (9)
    • Basu S, Risérus U, Turpeinen A, Vessby B. 2000a. Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clinical Science 99(6):511-516.
    • Gaullier JM, Halse J, Høivik HO, Høye K, Syvertsen C, Nurminiemi M, Hassfeld C, Einerhand A, O'Shea M, Gudmundsen O. 2007. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. British Journal of Nutrition 97(3):550-560.
    • Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. 2004. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. The American Journal of Clinical Nutrition 79:1118-1125.
    • Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. 2005. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. The Journal of Nutrition 135(4):778-784.
    • Larsen TM, Toubro S, Gundmensen O, Astrup A. 2006. Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat gain. The American Journal of Clinical Nutrition 83(3):606-612.
    • Smedman A, Basu S, Jovinge S, Fredrikson GN, Vessby B. 2005. Conjugated linoleic acid increased C-reactive protein in human subjects. British Journal of Nutrition 94(5):791-795.
    • Steck SE, Chalecki AM, Miller P, Conway J, Austin GL, Hardin JW, Albright CD, Thuillier P. 2007. Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans. The Journal of Nutrition 137(5):1188-1193.
    • Taylor JS, Williams SR, Rhys R, James P, Frenneaux MP. 2006. Conjugated linoleic acid impairs endothelial function. Arteriosclerosis, Thrombosis, and Vascular Biology 26(2):307-312.
    • Tholstrup T, Raff M, Straarup EM, Lund P, Basu S, Bruun JM. 2008. An oil mixture with trans-10, cis-12 conjugated linoleic acid increases markers of inflammation and in vivo lipid peroxidation compared with cis-9, trans-11 conjugated linoleic acid in postmenopausal women. The Journal of Nutrition 138(8):1445-1451.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if your goal is to achieve weight loss.

    Gegenanzeigen

    Do not use if you are pregnant (HC 2010).

    Von Health Canada zitierte Quellen (2)
    • HC 2010: Health Canada: Prenatal Nutrition Guidelines for health Professionals: Gestational weight gain [Accessed 2024 April 7]. Available from: https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/pdf/nutrition/prenatal/ewba-mbsa-eng.pdf
    • SC 2010 : Santé Canada : Lignes directrices sur la nutrition pendant la grossesse à l'intention des professionnels de la santé : Gain de poids pendant la grossesse. [Consulté le 7 avril 2024]. Disponible à : https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/pdf/nutrition/prenatal/ewba-mbsa-fra.pdf

    Do not use if you have cardiovascular disease (CVD), diabetes, metabolic syndrome or insulin resistance (Tholstrup et al. 2008; Gaullier et al. 2007; Steck et al. 2007; Larsen et al. 2006; Taylor et al. 2006; Gaullier et al. 2005; Smedman et al. 2005; Gaullier et al. 2004; Moloney et al. 2004; Basu et al. 2000a,b).

    Von Health Canada zitierte Quellen (10)
    • Basu S, Risérus U, Turpeinen A, Vessby B. 2000a. Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clinical Science 99(6):511-516.
    • Gaullier JM, Halse J, Høivik HO, Høye K, Syvertsen C, Nurminiemi M, Hassfeld C, Einerhand A, O'Shea M, Gudmundsen O. 2007. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. British Journal of Nutrition 97(3):550-560.
    • Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. 2004. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. The American Journal of Clinical Nutrition 79:1118-1125.
    • Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. 2005. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. The Journal of Nutrition 135(4):778-784.
    • Larsen TM, Toubro S, Gundmensen O, Astrup A. 2006. Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat gain. The American Journal of Clinical Nutrition 83(3):606-612.
    • Moloney F, Yeow TP, Mullen A, Nolan JJ, Roche HM. 2004. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. The American Journal of Clinical Nutrition 80(4):887-895.
    • Smedman A, Basu S, Jovinge S, Fredrikson GN, Vessby B. 2005. Conjugated linoleic acid increased C-reactive protein in human subjects. British Journal of Nutrition 94(5):791-795.
    • Steck SE, Chalecki AM, Miller P, Conway J, Austin GL, Hardin JW, Albright CD, Thuillier P. 2007. Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans. The Journal of Nutrition 137(5):1188-1193.
    • Taylor JS, Williams SR, Rhys R, James P, Frenneaux MP. 2006. Conjugated linoleic acid impairs endothelial function. Arteriosclerosis, Thrombosis, and Vascular Biology 26(2):307-312.
    • Tholstrup T, Raff M, Straarup EM, Lund P, Basu S, Bruun JM. 2008. An oil mixture with trans-10, cis-12 conjugated linoleic acid increases markers of inflammation and in vivo lipid peroxidation compared with cis-9, trans-11 conjugated linoleic acid in postmenopausal women. The Journal of Nutrition 138(8):1445-1451.

    Bekannte Nebenwirkungen

    When using this product you may experience gastrointestinal discomfort/disturbances (Gaullier et al. 2007; Pinkoski et al. 2006; Berven et al. 2000; Blankson et al. 2000).

    Von Health Canada zitierte Quellen (4)
    • Berven G, Bye A, Hals O, Blankson H, Fagertun H, Thom E, Wadstein J, Gudmundsen O. 2000. Safety of conjugated linoleic acid (CLA) in overweight and obese human volunteers. European Journal of Lipid Science and Technology 102(7):455-462.
    • Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. 2000. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. The Journal of Nutrition 130(12):2943-2948.
    • Gaullier JM, Halse J, Høivik HO, Høye K, Syvertsen C, Nurminiemi M, Hassfeld C, Einerhand A, O'Shea M, Gudmundsen O. 2007. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. British Journal of Nutrition 97(3):550-560.
    • Pinkoski C, Chilibeck PD, Candow DG, Esliger D, Ewaschuk JB, Facci M, Farthing JP, Zello GA. 2006. The effects of conjugated linoleic acid supplementation during resistance training. Medicine and Science in Sports and Exercise 38(2):339-348.

    Monografie von Health Canada vom 10. Januar 2025

  • Lepidium meyenii
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    Maca - Lepidium Meyenii

    Art der Anwendung: Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Anwendungsbedingung: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Gilt für Produkte: providing 0.6 g or more dried root/hypocotyl, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a blood pressure condition (Valentova et al. 2008).

    Von Health Canada zitierte Quellen (1)
    • Valentova K, Stejskal D, Bartek J, Dvoráckova S, Kren V, Ulrichova J, Simanek V. Maca (Lepidium meyenii) and yacon (Smallanthus sonchifolius) in combination with silymarin as food supplements: in vivo safety assessment. Food and Chemical Toxicology 2008;46(3):1006-1013. PubMed Randomisierte Studie

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).

    Von Health Canada zitierte Quellen (2)
    • Dording CM, Fsher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience Therapy and Therapeutics 2008;14(3):182-191. PubMed Randomisierte Studie
    • Gonzales GF, Gonzales-Castaneda GC. The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii). Evidence Based Complementary Alternative Medicine 2009;6(3):315-316. PubMed

    Anwendungsbedingung: Healthy mood balance; Sexual health.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression (Brotto 2010; Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).

    Von Health Canada zitierte Quellen (3)
    • Brotto LA. The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Archives of Sexual Behavior 2010;39(2):221-239. PubMed Übersichtsartikel
    • Dording CM, Fsher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience Therapy and Therapeutics 2008;14(3):182-191. PubMed Randomisierte Studie
    • Gonzales GF, Gonzales-Castaneda GC. The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii). Evidence Based Complementary Alternative Medicine 2009;6(3):315-316. PubMed

    Monografie von Health Canada vom 27. September 2024

  • Panax ginseng
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    PANAX GINSENG

    Art der Anwendung: Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Vuksan et al. 2008; Seely et al. 2008; Sievenpiper et al. 2006; ESCOP 2003; Tetsutani et al. 2000; Sotaniemi et al. 1995; Chin 1991).

    Von Health Canada zitierte Quellen (8)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Chin RKH. Ginseng and common pregnancy disorders. Asia-Oceania Journal of Obstetrics and Gynaecology 1991;17(4):379-380. PubMed
    • ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • Seely D, Dugoua JJ, Perri D, Mills E, Koren G. Safety and efficacy of Panax ginseng during pregnancy and lactation. The Canadian Journal of Clinical Pharmacology 2008;15(1):e87-e94.
    • Sievenpiper JL, Sung MK, Buono MD, Seung-Lee K, Nam KY, Arnason JT, Leiter LA, Vuksan V. Korean red ginseng rootlets decrease acute postprandial glycemia: results from sequential preparation- and dose-finding studies. Journal of the American College of Nutrition 2006;25(2):100-107. PubMed Randomisierte Studie
    • Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 1995;18(10):1373-1375. PubMed Klinische Studie
    • Tetsutani T, Yamamura M, Yamaguchi T, Onoyama O, Kono M. Can red ginseng control blood glucose in diabetic patients. The Ginseng Review 2000;28:44-47.
    • Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Buono MD, Lee KS, Leiter LA, Nam KY, Arnason JT, Choi M, Naeem A. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutrition, Metabolism & Cardiovascular Diseases 2008;18(1):46-56. PubMed Randomisierte Studie

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking antidepressant medication, blood thinners or digoxin (Brinker 2010; Lee et al. 2008a; Dasgupta and Reyes 2005; Janetzki and Morreale 1997; Gonzalez-Seijo et al. 1995; Shader and Greenblatt 1988; Jones and Runikis 1987; Shader and Greenblatt 1985).

    Von Health Canada zitierte Quellen (8)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Dasgupta A, Reyes MA. Effect of Brazillian, Indian, Siberian, Asian, and North American ginseng on serum digoxin measurement by immunoassays and binding of digoxin-like immunoreactive components of ginseng with Fab Fragment of antidigoxin antibody (Digiband). American Journal of Clinical Pathology 2005;124(2):229-236. PubMed
    • Gonzalez-Seijo JC, Ramos YM, Lastra I. Manic episode and ginseng: report of a possible case. Journal of Clinical Psychopharmacology 1995;15(6):447-448. PubMed Fallbericht
    • Janetzki K, Morreale AP. Probable interaction between warfarin and ginseng. American Journal of Health-System Pharmacy 1997;54(6):692-693.
    • Jones BD, Runikis AM. Interaction of ginseng with phenelzine. Journal of Clinical Pharmacology 1987;7(3):201-202. PubMed Fallbericht
    • Lee SH, Ahn YM, Ahn SY, Doo HK, Lee BC. Interaction between warfarin and Panax ginseng in ischemic stroke patients. The Journal of Alternative and Complementary Medicine 2008a;14(6):715-721. PubMed Randomisierte Studie
    • Shader RI, Greenblatt DJ. Bees, ginseng and MAOIs revisited. Journal of Clinical Psychopharmacology 1988;8(4):235. PubMed Fallbericht
    • Shader RI, Greenblatt DJ. Phenelzine and the dream machine – ramblings and reflections. Journal of Clinical Psychopharmacology 1985;5(2):65. PubMed Fallbericht

    Gegenanzeigen

    Anwendungsbedingung: Traditional Chinese Medicine.

    Do not use in cases of yin deficiency with heat signs, heat excess, or in the absence of significant qi deficiency (Bensky et al. 2004).

    Von Health Canada zitierte Quellen (1)
    • Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.

    Bekannte Nebenwirkungen

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience insomnia, anxiety or headaches (Lee et al. 2008b; Vuksan et al 2008; de Andrade et al.2007; Sievenpiper et al. 2006; Coon and Ernst 2002; Ellis and Reddy 2002; Scaglione et al. 2001; Siegel 1979).

    Von Health Canada zitierte Quellen (8)
    • Coon JT, Ernst E. Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Safety 2002;25(5):323-344. PubMed Systematische Übersicht
    • de Andrade E, de Masquita AA, de Almeida Claro J, de Andrade PM, Ortiz V, Paranhos M, Srougi M. Study of the efficacy of Korean Red Ginseng in the treatment of erectile dysfunction. Asian Journal of Andrology 2007;9(2):241-244.
    • Ellis JM, Reddy P. Effects of Panax ginseng on quality of life. The Annals of Pharmacotherapy 2002;36(3):375-379. PubMed Randomisierte Studie
    • Lee ST, Chu K, Sim JY, Heo JH, Kim M. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Disease and Associated Disorders 2008b;22(3):222-226. PubMed Randomisierte Studie
    • Scaglione F, Weiser K, Alessandria M. Effects of the standardised ginseng extract G115 in patients with chronic bronchitis. Clinical Drug Investigation 2001;21(1):41-45.
    • Siegel RK. Ginseng abuse syndrome. Problems with the panacea. The Journal of the American Medical Association 1979;241(15):1614-1615. PubMed
    • Sievenpiper JL, Sung MK, Buono MD, Seung-Lee K, Nam KY, Arnason JT, Leiter LA, Vuksan V. Korean red ginseng rootlets decrease acute postprandial glycemia: results from sequential preparation- and dose-finding studies. Journal of the American College of Nutrition 2006;25(2):100-107. PubMed Randomisierte Studie
    • Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Buono MD, Lee KS, Leiter LA, Nam KY, Arnason JT, Choi M, Naeem A. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutrition, Metabolism & Cardiovascular Diseases 2008;18(1):46-56. PubMed Randomisierte Studie

    1 im Text zitierte Studie hat keine passende Angabe im Literaturverzeichnis der Monografie (siehe Auffälligkeiten auf der Quellenseite).

    Monografie von Health Canada vom 27. Juni 2025

  • Silybum marianum
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    MILK THISTLE - SILYBUM MARIANUM

    Art der Anwendung: Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills et al. 2006).

    Von Health Canada zitierte Quellen (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills E, Dugoua J, Perri D, Koren G. Herbal Medicines in Pregnancy and Lactation : An Evidence-Based Approach. London (UK): Taylor and Francis Medical; 2006.

    Bekannte Nebenwirkungen

    Stop use if hypersensitivity/allergy occurs (Geier et al. 1990; Mironets et al. 1990).

    Von Health Canada zitierte Quellen (2)
    • Geier J, Fuchs Th, Wahl R. [Anaphylactic shock due to an extract of Silybum marianum in a patient with immediate-type allergy to Kiwi fruit]. Anaphylaktischer Schock durch einen Mariendistel-Extrakt bei Soforttyp-Allergie auf Kiwi. Allergologie 1990;13(10):387-388 (in German).
    • Mironets VI, Krasovskaia EA, Polischuk II. [A case of urticaria during carsil treatment]. Vrachebnoe Delo 1990;(7):86-87 (in Russian).

    Monografie von Health Canada vom 26. Juni 2026

  • Vaccinium angustifolium
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    Blueberry

    Art der Anwendung: Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Gilt für Produkte: providing 5 grams or more of total dried fruit, per day; Products providing 37.5 grams or more of total fresh fruit, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (ASHP 2005; Franco et al. 2004; IOM 2001; Hansten et al. 1997).

    Von Health Canada zitierte Quellen (4)
    • ASHP 2005: American Society of Health-System Pharmacists. American Hospital Formulary Service (AHFS) Drug Information. Philadelphia (PA): Lippincott Williams and Wilkins; 2005.
    • Franco V, Polanczyk CA, Clausell N, Rohde LE. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. The American Journal of Medicine 2004;166(10):651-656. PubMed Randomisierte Studie
    • Hansten PD, Horn JR, editors. Drug Interactions Analysis and Management. Vancouver (WA): Applied Therapeutics Inc.; 1997.
    • IOM 2001: Institute of Medicine. Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington (DC): National Academies Press; 2001.

    Monografie von Health Canada vom 29. August 2025

  • Vaccinium myrtillus
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Art der Anwendung: Buccal (Blumenthal et al. 2000)

    Vorsichtsmaßnahmen und Warnhinweise

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Monografie von Health Canada vom 30. Januar 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Art der Anwendung: Oral (Blumenthal et al. 2000)

    Vorsichtsmaßnahmen und Warnhinweise

    Anwendungsbedingung: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Anwendungsbedingung: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Monografie von Health Canada vom 25. Oktober 2024

  • Punica granatum
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen
  • Huile de poisson
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    FISH OIL

    Art der Anwendung: Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Anwendungsbedingung: Pain of rheumatoid arthritis.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Anwendungsbedingung: Healthy mood balance.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.

    Monografie von Health Canada vom 25. September 2026

  • Borago officinalis
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

Sie betreffen die Zutat, nicht dieses Produkt oder seine Dosis. Sie ersetzen keinen ärztlichen Rat.

Liste in der amtlichen Überarbeitung vom (Register: Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise).

Verpackung fotografieren

Ist eine Angabe zu diesem Produkt falsch oder veraltet, ob Sie Leser oder Marke sind? Schreiben Sie an contact@compoatlas.com: Jede Korrektur wird im Korrekturprotokoll veröffentlicht.

Liste aus dem Jahr 2016. Fotografieren Sie die Verpackung, um Änderungen zu prüfen.

Eingabetaste zum Analysieren, Umschalt+Eingabetaste für eine neue Zeile